Live Analyst Rating Changes 19690 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/James Rose
BARC

James Rose

Barclays
Wall Street Analyst
★★☆☆☆
#2459
on 13Foresight · ranked by our own returns
48%
Success Rate
-6.6%
Average Return
13 of 27 calls profitable · -16.4% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 48% of James Rose's ratings turned a profit when each position was held for 1 year — averaging -6.6% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

36 Buy 2 Hold 1 Sell
James's Stock Coverage 19 ratings · 2026-08-07
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
GB:RTO
Rentokil Initial
 Aug 05, 2026 BUY Strong Buy
+41.4% avg upside
19 analysts
$630.00
73.35% Upside
 · ·
GB:DPLM
Diploma
 Jul 17, 2026 BUY Strong Buy
-27.5% avg upside
8 analysts
$8600.00
12.08% Upside
 -0.5% ·
GB:EXPN
Experian
 Jul 15, 2026 BUY Buy
+238.2% avg upside
20 analysts
 — +8.1% ·
GB:ZIG
ZIGUP plc
 Jul 09, 2026 BUY Strong Buy
+1521.9% avg upside
5 analysts
$575.00
24.07% Upside
 +3.2% ·
GB:SRP
Serco Group plc
 Jun 29, 2026 BUY Buy
+1.7% avg upside
8 analysts
$300.00
15.38% Upside
 +10.2% ·
GB:BNZL
Bunzl plc
 Jun 24, 2026 HOLD Buy
-4.3% avg upside
16 analysts
$2650.00
6.36% Downside
 +5.4% ·
GB:RS1
RS Group PLC
 May 21, 2026 BUY Strong Buy
+2.2% avg upside
10 analysts
$800.00
7.25% Upside
 +2.8% ·
NL:RAND
Randstad Holding NV
 Mar 11, 2026 SELL Sell
+6.5% avg upside
16 analysts
$42.00
11.68% Upside
 -49.7% ·
GB:CPI
Capita plc
 Mar 11, 2026 BUY Strong Buy
+2913.3% avg upside
5 analysts
$600.00
135.75% Upside
 -9.6% ·
FR:ERF
Eurofins Scientific
 Jul 16, 2025 HOLD Buy
+43.8% avg upside
17 analysts
$54.00
22.72% Downside
 +17.3% ·
MX:AZEN
Azelis Group N.V.
 Jun 02, 2025 BUY Buy
+36.6% avg upside
11 analysts
$497.97
138.06% Upside
 -42.4% ·
GB:ITRK
Intertek
 Nov 27, 2024 SELL Hold
+791.9% avg upside
23 analysts
$4750.00
18.72% Downside
 +2.1% ·
CH:SGSN
SGS SA
 Nov 21, 2024 SELL Buy
+1058.9% avg upside
26 analysts
$91.00
6.08% Downside
 -7.9% ·
FR:BVI
Bureau Veritas
 Oct 24, 2024 BUY Buy
+3.8% avg upside
25 analysts
$33.00
15.98% Upside
 +1.3% ·
GB:DCC
DCC plc
 Dec 16, 2022 SELL Strong Buy
-1.3% avg upside
10 analysts
$4100.00
35.77% Downside
 -39.7% ·
BZLFY
Bunzl
 Dec 16, 2022 SELL Sell
+52.0% avg upside
4 analysts
$37.04
94.62% Upside
 -15.8% ·
GB:PAGE
PageGroup
 Oct 19, 2022 HOLD Hold
+47.3% avg upside
9 analysts
$600.00
220.71% Upside
 -7.0% ·
GB:HAS
Hays plc
 Jul 18, 2022 BUY Buy
+4565.0% avg upside
12 analysts
$190.00
204.63% Upside
 -16.3% ·
GB:TPK
Travis Perkins
 Jan 24, 2022 HOLD Buy
+1275.9% avg upside
16 analysts
$1545.00
132.94% Upside
 -30.2% ·
🔒 14 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
James Rose — Frequently Asked Questions
How accurate are James Rose's stock ratings?
Based on the calls 13Foresight could measure, about 48% of James's ratings were profitable over a one-year hold, with an average return of -6.6% per rating, or -16.4% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is James ranked on 13Foresight?
James Rose is currently ranked #2459 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does James cover?
James most recently has ratings on GB:RTO, GB:DPLM, GB:EXPN, GB:ZIG, GB:SRP, GB:BNZL, GB:RS1, NL:RAND, GB:CPI, FR:ERF, MX:AZEN, GB:ITRK and 7 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.